White Ted's Form 4 filing
Verrica Pharmaceuticals Inc. (VRCA) · filed Nov 16, 2023
- Accession no.
- 0001209191-23-055528
- Filed
- Nov 16, 2023
- Trade date
- Nov 14-15, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $99.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| White TedCIK 0001741964 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2023 | Common Stock | SSaleDisposed | −22,141 | $2.93 | −$64,873.13 | 181,648 | Direct | |
| Nov 15, 2023 | Common Stock | SSaleDisposed | −11,558 | $2.97 | −$34,327.26 | 170,090 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.